Journal article
Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment
European archives of psychiatry and clinical neuroscience, v 254(5), pp 318-325
Oct 2004
PMID: 15365707
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
In vitro, animal studies and acute short-term clinical studies suggest clozapine releases prolactin but the effect is much smaller than that of typical antipsychotics. Repeated early morning trough measures of plasma clozapine and prolactin levels on each subject were studied during the course of a double-blind dose-response clozapine study. After a 4-week 10 mg/day haloperidol trial and a one-week washout, treatment- refractory schizophrenics were successively randomized to 100, 300,or 600 mg/day of clozapine for a 16- week treatment. The statistical analyses included 35 subjects (19 females and 16 males). The within-subject correlation of prolactin levels was 0.32 with clozapine levels and 0.75 with haloperidol levels. An increment of 100 ng/ml in clozapine level yielded an average increment of 0.45 ng/ml of prolactin levels in females and of 0.15 ng/ml in males. An increment of 1 ng/ml in haloperidol level yielded an average increment of 2.6 ng/ml of prolactin levels in females and of 1.5 ng/ml in males. At least one fourth of patients demonstrated a significant and strong (r > 0.6) correlation between clozapine and prolactin levels. This study suggests that clozapine has effects on prolactin levels but effects are small and may be more evident in some individuals, particularly females.
Metrics
Details
- Title
- Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment
- Creators
- Jose de Leon - Eastern State HospitalFrancisco J Diaz - Universidad Nacional de ColombiaRichard C Josiassen - University of PennsylvaniaGeorge M Simpson - University of Southern California
- Publication Details
- European archives of psychiatry and clinical neuroscience, v 254(5), pp 318-325
- Publisher
- Springer Nature
- Grant note
- MH-47162 / NIMH NIH HHS
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Psychiatry
- Web of Science ID
- WOS:000224096000007
- Scopus ID
- 2-s2.0-4744374208
- Other Identifier
- 991021889914204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Clinical Neurology
- Psychiatry